OVERVIEW
A 10-year-old Golden Retriever diagnosed with histiocytic sarcoma. Treatment began based on medical literature that suggested the tumor could bear KRAS and PTPN11 mutations, which are associated with response to the targeted drug cobimetinib, after an intial course of radiation therapy.